Office of the Director, National Institutes of Health; Notice of Meeting, 33098 [2013-13180]
Download as PDF
sroberts on DSK5SPTVN1PROD with NOTICES
33098
Federal Register / Vol. 78, No. 106 / Monday, June 3, 2013 / Notices
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide insights into
customer or stakeholder perceptions,
experiences and expectations, provide
an early warning of issues with service,
or focus attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
Agency and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
Feedback collected under this generic
clearance will provide useful
information, but it will not yield data
that can be generalized to the overall
population. This type of generic
clearance for qualitative information
will not be used for quantitative
information collections that are
designed to yield reliably actionable
results, such as monitoring trends over
time or documenting program
performance. Such data uses require
more rigorous designs that address: the
target population to which
generalizations will be made, the
sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
No comments were received in
response to the 60-day notice published
in the Federal Register of December 22,
2010 (75 FR 80542).
Below we provide NINDS’s projected
average estimates for the next three
years:
Current Actions: New collection of
information.
Type of Review: New Collection.
Affected Public: Individuals and
Households, Businesses and
Organizations, State, Local or Tribal
Government.
Average Expected Annual Number of
activities: 6.
Respondents: 14,700.
Annual responses: 24,700.
Frequency of Response: Once per
request for 5 activities, twice per request
for 1 activity.
Average minutes per response: 57.
VerDate Mar<15>2010
16:40 May 31, 2013
Jkt 229001
Burden hours: 5750.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid
Office of Management and Budget
control number.
Dated: May 24, 2013.
Story Landis,
Director, National Institute of Neurological
Disorders and Stroke, National Institutes of
Health.
[FR Doc. 2013–13074 Filed 5–31–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting hosted by the
NIH Scientific Management Review
Board (SMRB). Presentations and
discussions will address optimal
approach to assessing the value of
biomedical research supported by NIH.
The NIH Reform Act of 2006 (Pub.L.
109–482) provides organizational
authorities to HHS and NIH officials to:
(1) Establish or abolish national research
institutes; (2) reorganize the offices
within the Office of the Director, NIH
including adding, removing, or
transferring the functions of such offices
or establishing or terminating such
offices; and (3) reorganize, divisions,
centers, or other administrative units
within an NIH national research
institute or national center including
adding, removing, or transferring the
functions of such units, or establishing
or terminating such units. The purpose
of the SMRB is to advise appropriate
HHS and NIH officials on the use of
these organizational authorities and
identify the reasons underlying the
recommendations.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Scientific
Management Review Board (SMRB).
Date: June 4, 2013.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: The meeting topics will include:
1) an update from the SMRB’s Value of
Biomedical Research Working Group, and 2)
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
presentations that explore approaches to
studying the value of biomedical research.
Time will be allotted on the agenda for
public comment. Sign up for public
comments will begin approximately at 7:30
a.m. on June 4, 2013, and will be restricted
to one sign-in per person. In the event that
time does not allow for all those interested
to present oral comments, any interested
person may file written comments with the
committee by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Place: National Institutes of Health,
Building 1, 3rd Floor, Wilson Hall, 1 Center
Drive, Bethesda, MD 20892.
Contact Person: Juanita Marner, Office of
Science Policy, Office of the Director, NIH,
National Institutes of Health, 6705 Rockledge
Drive, Suite 750, Bethesda, MD 20892.
smrb@mail.nih.gov, (301) 435–1770.
This notice is being published less than 15
days prior to the meeting due to scheduling
conflicts with the presenters.
The meeting will also be webcast. The draft
meeting agenda and other information about
the SMRB, including information about
access to the webcast, will be available at
https://smrb.od.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals From
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: May 30, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–13180 Filed 5–31–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Co-Exclusive
Licenses: Multi-Focal Structured
Illumination Microscopy Systems and
Methods
AGENCY:
National Institutes of Health,
HHS.
E:\FR\FM\03JNN1.SGM
03JNN1
Agencies
[Federal Register Volume 78, Number 106 (Monday, June 3, 2013)]
[Notices]
[Page 33098]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-13180]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting hosted by
the NIH Scientific Management Review Board (SMRB). Presentations and
discussions will address optimal approach to assessing the value of
biomedical research supported by NIH.
The NIH Reform Act of 2006 (Pub.L. 109-482) provides organizational
authorities to HHS and NIH officials to: (1) Establish or abolish
national research institutes; (2) reorganize the offices within the
Office of the Director, NIH including adding, removing, or transferring
the functions of such offices or establishing or terminating such
offices; and (3) reorganize, divisions, centers, or other
administrative units within an NIH national research institute or
national center including adding, removing, or transferring the
functions of such units, or establishing or terminating such units. The
purpose of the SMRB is to advise appropriate HHS and NIH officials on
the use of these organizational authorities and identify the reasons
underlying the recommendations.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Scientific Management Review Board (SMRB).
Date: June 4, 2013.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: The meeting topics will include: 1) an update from the
SMRB's Value of Biomedical Research Working Group, and 2)
presentations that explore approaches to studying the value of
biomedical research. Time will be allotted on the agenda for public
comment. Sign up for public comments will begin approximately at
7:30 a.m. on June 4, 2013, and will be restricted to one sign-in per
person. In the event that time does not allow for all those
interested to present oral comments, any interested person may file
written comments with the committee by forwarding the statement to
the Contact Person listed on this notice. The statement should
include the name, address, telephone number and when applicable, the
business or professional affiliation of the interested person.
Place: National Institutes of Health, Building 1, 3rd Floor,
Wilson Hall, 1 Center Drive, Bethesda, MD 20892.
Contact Person: Juanita Marner, Office of Science Policy, Office
of the Director, NIH, National Institutes of Health, 6705 Rockledge
Drive, Suite 750, Bethesda, MD 20892. smrb@mail.nih.gov, (301) 435-
1770.
This notice is being published less than 15 days prior to the
meeting due to scheduling conflicts with the presenters.
The meeting will also be webcast. The draft meeting agenda and
other information about the SMRB, including information about access
to the webcast, will be available at https://smrb.od.nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals From Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: May 30, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-13180 Filed 5-31-13; 8:45 am]
BILLING CODE 4140-01-P